Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 561,606 |
|
|||||
| News | - | ||||||
| Day High | 1.01 | Low High |
|||||
| Day Low | 0.92 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Veru Inc | VERU | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0449 | 4.7% | 1.00 | 00:00:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.9212 | 0.92 | 1.01 | 1.01 | 0.9551 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,692 | 561,606 | $ 0.9798299 | $ 550,278 | - | 0.6606 - 6.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:11 | 30 | $ 1.00 | USD |
Veru Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 91.18M | 90.28M | - | 39.35M | -83.78M | -0.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Veru News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VERU Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.96 | 1.02 | 0.890501 | 0.9520978 | 659,895 | 0.04 | 4.17% |
| 1 Month | 0.99 | 1.14 | 0.88 | 0.9939982 | 654,796 | 0.01 | 1.01% |
| 3 Months | 1.04 | 1.14 | 0.6606 | 0.8948139 | 959,718 | -0.04 | -3.85% |
| 6 Months | 1.00 | 1.45 | 0.6606 | 1.05 | 1,032,829 | 0.00 | 0.0% |
| 1 Year | 5.58 | 6.57 | 0.6606 | 2.53 | 1,876,599 | -4.58 | -82.08% |
| 3 Years | 3.03 | 24.56 | 0.6606 | 11.08 | 4,936,858 | -2.03 | -67.0% |
| 5 Years | 1.51 | 24.56 | 0.6606 | 10.75 | 3,082,198 | -0.51 | -33.77% |
Veru Description
| Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States. |
